* Core Laboratories NV CLB.N reported quarterly adjusted
earnings of 18 cents per share for the quarter ended in
September. The mean expectation of nine analysts for the quarter
was for earnings of 15 cents per share.
* Revenue rose 6.8% to $125.97 million from a year ago;
analysts
expected $125.82 million.
* Core Laboratories NV's reported EPS for the quarter was 16
cents.
* The mean earnings estimate of analysts had fallen by
about 16.1%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Core Laboratories NV shares had risen by 48.4% this
quarter and
lost 10.4% so far this year.
* The company reported quarterly net income of $7.52
million.
* Wall Street's median 12-month price target for Core
Laboratories
NV is $20.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 5
"hold" and 2 "sell" or "strong sell."
This summary was machine generated from Refinitiv data October
26 at 11:24 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 0.15 0.18 Beat
Jun. 30 2022 0.14 0.12 Missed
Mar. 31 2022 0.09 0.08 Missed
Dec. 31 2021 0.20 0.20 Met